The transcription factor E74-like factor controls quiescence of endothelial cells and their resistance to myeloablative treatments in bone marrow

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 5, 2011, Pages 1185-1191

  Sivina, Mariela ^a   Yamada, Takeshi ^a   Park, Chun Shik ^a   Puppi, Monica ^a   Coskun, Suleyman ^b   Hirschi, Karen ^b,c   Lacorazza, H Daniel ^a,b,c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

endothelial function; gene expression; quiescence; transcription factor

Indexed keywords

CD31 ANTIGEN; CYCLIN DEPENDENT KINASE 4; FLUOROURACIL; TRANSCRIPTION FACTOR ELF 1;

ANIMAL CELL; ARTICLE; BLOOD VESSEL; BONE MARROW; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MOUSE; MYELOABLATIVE CONDITIONING; NONHUMAN; NULL ALLELE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEADY STATE; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; BONE MARROW CELLS; CELL AGING; CELL CYCLE; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN-DEPENDENT KINASE 4; DNA-BINDING PROTEINS; DRUG RESISTANCE; ENDOTHELIAL CELLS; FLUOROURACIL; HUMANS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOABLATIVE AGONISTS; NEOVASCULARIZATION, PHYSIOLOGIC; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 79955605755     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.224436     Document Type: Article

References (33)

1. Tzachanis D, Lafuente EM, Li L, Boussiotis VA. Intrinsic and extrinsic regulation of T lymphocyte quiescence. Leuk Lymphoma. 2004;45: 1959-1967. (Pubitemid 39232844)
2. Kopp HG, Avecilla ST, Hooper AT, Rafii S. The bone marrow vascular niche: home of HSC differentiation and mobilization. Physiology (Bethesda). 2005;20:349-356. (Pubitemid 41457400)
3. Kopp HG, Avecilla ST, Hooper AT, Shmelkov SV, Ramos CA, Zhang F, Rafii S. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood. 2005;106:505-513. (Pubitemid 40981244)
4. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood. 2005;106:1901-1910. (Pubitemid 41291700)
5. Sharrocks AD. The ETS-domain transcription factor family. Nat Rev Mol Cell Biol. 2001;2:827-837. (Pubitemid 33674083)
6. Lacorazza HD, Nimer SD. The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesis. Blood Cells Mol Dis. 2003;31: 342-350. (Pubitemid 37433875)
7. Moore SD, Offor O, Ferry JA, Amrein PC, Morton CC, Dal Cin P. ELF4 is fused to ERG in a case of acute myeloid leukemia with a t(X; 21)(q25-26;q22). Leuk Res. 2005.
8. Alcalay M, Meani N, Gelmetti V, Fantozzi A, Fagioli M, Orleth A, Riganelli D, Sebastiani C, Cappelli E, Casciari C, Sciurpi MT, Mariano AR, Minardi SP, Luzi L, Muller H, Di Fiore PP, Frosina G, Pelicci PG. Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest. 2003;112: 1751-1761. (Pubitemid 38063733)
9. Park DJ, Vuong PT, de Vos S, Douer D, Koeffler HP. Comparative analysis of genes regulated by PML/RAR- and PLZF/RAR- in response to retinoic acid using oligonucleotide arrays. Blood. 2003;102: 3727-3736. (Pubitemid 37409394)
10. Muller-Tidow C, Steffen B, Cauvet T, Tickenbrock L, Ji P, Diederichs S, Sargin B, Kohler G, Stelljes M, Puccetti E, Ruthardt M, deVos S, Hiebert SW, Koeffler HP, Berdel WE, Serve H. Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. Mol Cell Biol. 2004;24:2890-2904. (Pubitemid 38381278)
11. Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV. Tumor promoting properties of the ETS protein MEF in ovarian cancer. Oncogene. 2007.
12. Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD. The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells. Immunity. 2002;17: 437-449. (Pubitemid 35223533)
13. Lacorazza HD, Yamada T, Liu Y, Miyata Y, Sivina M, Nunes J, Nimer SD. The transcription factor MEF/ELF4 regulates the quiescence of primitive hematopoietic cells. Cancer Cell. 2006;9:175-187. (Pubitemid 43357944)
14. Yamada T, Park CS, Mamonkin M, Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8 T cells via the Kruppel-like factors KLF4 and KLF2. Nat Immunol. 2009;10:618-626.
15. Yamada T, Gierach K, Lee PH, Wang X, Lacorazza HD. Cutting edge: expression of the transcription factor E74-like factor 4 is regulated by the mammalian target of rapamycin pathway in CD8 T cells. J Immunol. 2010;185:3824-3828.
16. De Val S, Black BL. Transcriptional control of endothelial cell development. Dev Cell. 2009;16:180-195.
17. Dejana E, Taddei A, Randi AM. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta. 2007;1775:298-312. (Pubitemid 46899342)
18. Dube A, Thai S, Gaspar J, Rudders S, Libermann TA, Iruela-Arispe L, Oettgen P. Elf-1 is a transcriptional regulator of the Tie2 gene during vascular development. Circ Res. 2001;88:237-244. (Pubitemid 32147314)
19. Gaspar J, Thai S, Voland C, Dube A, Libermann TA, Iruela-Arispe ML, Oettgen P. Opposing functions of the Ets factors NERF and ELF-1 during chicken blood vessel development. Arterioscler Thromb Vasc Biol. 2002; 22:1106-1112. (Pubitemid 34764860)
20. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, Leiden JM. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9:555-563. (Pubitemid 28499206)
21. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, Favier R, Bernstein A. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity. 2000;13:167-177.
22. Pham VN, Lawson ND, Mugford JW, Dye L, Castranova D, Lo B, Weinstein BM. Combinatorial function of ETS transcription factors in the developing vasculature. Dev Biol. 2007;303:772-783. (Pubitemid 46341274)
23. Spyropoulos DD, Pharr PN, Lavenburg KR, Jackers P, Papas TS, Ogawa M, Watson DK. Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor. Mol Cell Biol. 2000;20:5643-5652. (Pubitemid 30482898)
24. Wang LC, Kuo F, Fujiwara Y, Gilliland DG, Golub TR, Orkin SH. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 1997;16:4374-4383. (Pubitemid 27298190)
25. Tavassoli M. Structure and function of sinusoidal endothelium of bone marrow. Prog Clin Biol Res. 1981;59B:249-256.
26. Kiel MJ, Morrison SJ. Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol. 2008;8:290-301. (Pubitemid 351432804)
27. Yin T, Li L. The stem cell niches in bone. J Clin Invest. 2006;116: 1195-1201.
28. Narayan K, Juneja S, Garcia C. Effects of 5-fluorouracil or total-body irradiation on murine bone marrow microvasculature. Exp Hematol. 1994;22:142-148. (Pubitemid 24118534)
29. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature. 1995;376:70-74.
30. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res. 1997;81:567-574. (Pubitemid 27432744)
31. Johnson SM, Torrice CD, Bell JF, Monahan KB, Jiang Q, Wang Y, Ramsey MR, Jin J, Wong KK, Su L, Zhou D, Sharpless NE. Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest. 2010;120: 2528-2536.
32. Tipping AJ, Pina C, Castor A, Hong D, Rodrigues NP, Lazzari L, May GE, Jacobsen SE, Enver T. High GATA-2 expression inhibits human hematopoietic stem and progenitor cell function by effects on cell cycle. Blood. 2009;113:2661-2672.
33. Horsley V, Aliprantis AO, Polak L, Glimcher LH, Fuchs E. NFATc1 balances quiescence and proliferation of skin stem cells. Cell. 2008;132: 299-310. (Pubitemid 351172432)